Search
for
Sort by
Research 121–150 of 141
- Diseases of the Canine Prostate Gland
- Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- FDA approves label addition for PDE-5 inhibitor
- 1194: The Long Term Effects of Doxazosin, Finasteride, and the Combination on Sexual Function in Men Participating in the MTOPS Study
- 311 Novel Penile Ultrasound Technique to Explain Mechanism of Erectile Dysfunction (ED) in Young Patients using Finasteride for Androgenic Alopecia
- Wider clinical applications of fumaric acid esters: A useful option in psoriasis patients with multiple sclerosis
- The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis
- IP28-24 RISK OF ERECTILE DYSFUNCTION AMONG REPRODUCTIVE-AGED MEN FOLLOWING LOW-DOSE FINASTERIDE USE FOR ANDROGENETIC ALOPECIA: A PROPENSITY-MATCHED COHORT STUDY
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- MP11-05 THE UROLOGIC IMPACT OF LONG-TERM FINASTERIDE-1 MG USE FOR ANDROGENIC ALOPECIA: A MATCHED-COHORT DATABASE ANALYSIS
- Medical management of benign prostatic hyperplasia
- The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease
- Evaluation of risk of SSRI-associated impotence and low libido in men exposed to finasteride
- Patient-convenient Long-term Alopecia Treatment via PLGA Microsphere-Loaded Candlelit Microneedle
- 8 Finasteride-Associated Suicide and Depression in Men Treated for Hypogonadism and Impotence
- Contemporary drug synthesis
- Lower urinary tract symptoms (LUTS): The role of medications in improvement of quality of life
- 310 Clinical Improvements in Erectile Function and Mood in Hypogonadal Men Treated with 4.5% Nasal Testosterone Gel (Natesto)
- Phytotherapy in Benign Prostatic Hyperplasia
- Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Organic Causes of Erectile Dysfunction in Men Under 40
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- PD59-09 PHOSPHODIESTERASE INHIBITORS COULD REVERSE THE PROLIFERATION OF BPH EPITHELIAL CELLS INDUCED BY CD8+ T CELLS IN LOW ANDROGEN CONDITION
- Sexual Medicine Reviews—The Premiere Review Journal for the Field of Sexual Medicine
- Management of Recurrent Ischemic Priapism 2014: A Complex Condition with Devastating Consequences
- Impact of Hormones on Female Sexual Function and Dysfunction